Monday, 29 December 2025
Inflammatory bowel disease biologic blunts immune response to COVID-19, study finds

Added: 07.11.2021 20:50 | 195 views | 0 comments

Source: erj.ersjournals.com
Source: erj.ersjournals.com

Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body's immune response to COVID-19 infection, new research indicates.

More in www.sciencedaily.com »



Image with code
CommentsComments:
advertising


Copyright © 2008 - 2025 All Terra News - breaking news and headlines from around the world  - all rights reserved